Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua M. Eizen currently holds 206,554 shares of AN2 Therapeutics, Inc. (ANTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua M. Eizen has been a net seller of ANTX stock. They have purchased $0 and sold $24.8K worth of shares.
Joshua M. Eizen's most recent insider trade was on Jul 8, 2026, when they sold 5,945 shares at $4.17 per share.
Joshua M. Eizen serves as Executive at AN2 Therapeutics, Inc. (ANTX). They have executed 6 insider transactions totaling $24.8K over their tenure at the company.
Joshua M. Eizen holds the position of Executive at AN2 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Joshua M. Eizen has shown a selling trading pattern, with $0 in total purchases and $24.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joshua M. Eizen was on Jul 8, 2026, when they sold $24.8K worth of ANTX shares. This transaction involved 5,945 shares at $4.17 per share.
Joshua M. Eizen currently owns 206,554 shares of AN2 Therapeutics, Inc. (ANTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua M. Eizen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua M. Eizen has 6 Form 4 filings on record as an insider at AN2 Therapeutics, Inc..
Set alerts for Joshua M. Eizen and 40,000+ other insiders.